Cytomx Therapeutics Stock Filter Stocks by Fundamentals

CTMX Stock  USD 2.19  0.08  3.79%   
CytomX Therapeutics fundamentals help investors to digest information that contributes to CytomX Therapeutics' financial success or failures. It also enables traders to predict the movement of CytomX Stock. The fundamental analysis module provides a way to measure CytomX Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CytomX Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CytomX Price to Earning Analysis

CytomX Price to Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for CytomX Therapeutics is extremely important. It helps to project a fair market value of CytomX Stock properly, considering its historical fundamentals such as Price to Earning. Since CytomX Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CytomX Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CytomX Therapeutics' interrelated accounts and indicators.
0.890.650.90.56-0.84-0.60.670.380.19-0.120.90.90.40.891.00.56-0.53-0.120.440.840.82-0.120.56-0.03-0.29-0.12
0.890.410.820.71-0.77-0.790.430.260.31-0.150.730.90.670.890.860.22-0.77-0.150.560.650.89-0.150.82-0.22-0.52-0.15
0.650.410.36-0.12-0.630.050.780.26-0.330.280.610.43-0.150.240.660.750.10.280.210.90.180.280.00.570.340.28
0.90.820.360.69-0.7-0.690.490.310.35-0.220.910.870.440.950.90.45-0.64-0.220.40.620.89-0.220.65-0.27-0.45-0.22
0.560.71-0.120.69-0.22-0.980.080.180.49-0.680.590.690.880.740.530.01-0.94-0.680.270.260.88-0.680.88-0.77-0.94-0.68
-0.84-0.77-0.63-0.7-0.220.32-0.64-0.35-0.28-0.38-0.63-0.77-0.13-0.76-0.84-0.460.29-0.38-0.35-0.73-0.53-0.38-0.38-0.22-0.06-0.38
-0.6-0.790.05-0.69-0.980.32-0.13-0.19-0.50.57-0.59-0.73-0.93-0.76-0.570.00.970.57-0.36-0.33-0.890.57-0.940.730.930.57
0.670.430.780.490.08-0.64-0.130.180.050.120.630.58-0.050.390.690.850.020.120.30.860.240.120.030.210.140.12
0.380.260.260.310.18-0.35-0.190.18-0.10.110.250.390.240.350.36-0.01-0.220.110.10.260.280.110.210.04-0.060.11
0.190.31-0.330.350.49-0.28-0.50.05-0.1-0.030.20.350.350.470.190.05-0.45-0.03-0.050.00.33-0.030.38-0.69-0.45-0.03
-0.12-0.150.28-0.22-0.68-0.380.570.120.11-0.03-0.24-0.16-0.56-0.18-0.110.060.471.0-0.070.07-0.471.0-0.370.60.741.0
0.90.730.610.910.59-0.63-0.590.630.250.2-0.240.80.340.780.910.69-0.52-0.240.290.820.78-0.240.54-0.15-0.35-0.24
0.90.90.430.870.69-0.77-0.730.580.390.35-0.160.80.540.90.890.39-0.67-0.160.520.690.84-0.160.7-0.25-0.46-0.16
0.40.67-0.150.440.88-0.13-0.93-0.050.240.35-0.560.340.540.560.35-0.27-0.93-0.560.40.170.74-0.560.89-0.72-0.93-0.56
0.890.890.240.950.74-0.76-0.760.390.350.47-0.180.780.90.560.870.26-0.72-0.180.440.530.92-0.180.73-0.33-0.52-0.18
1.00.860.660.90.53-0.84-0.570.690.360.19-0.110.910.890.350.870.59-0.49-0.110.410.840.8-0.110.530.0-0.26-0.11
0.560.220.750.450.01-0.460.00.85-0.010.050.060.690.39-0.270.260.590.120.06-0.070.80.150.06-0.090.230.220.06
-0.53-0.770.1-0.64-0.940.290.970.02-0.22-0.450.47-0.52-0.67-0.93-0.72-0.490.120.47-0.32-0.25-0.850.47-0.980.690.90.47
-0.12-0.150.28-0.22-0.68-0.380.570.120.11-0.031.0-0.24-0.16-0.56-0.18-0.110.060.47-0.070.07-0.471.0-0.370.60.741.0
0.440.560.210.40.27-0.35-0.360.30.1-0.05-0.070.290.520.40.440.41-0.07-0.32-0.070.280.46-0.070.35-0.11-0.28-0.07
0.840.650.90.620.26-0.73-0.330.860.260.00.070.820.690.170.530.840.8-0.250.070.280.470.070.320.19-0.030.07
0.820.890.180.890.88-0.53-0.890.240.280.33-0.470.780.840.740.920.80.15-0.85-0.470.460.47-0.470.84-0.45-0.72-0.47
-0.12-0.150.28-0.22-0.68-0.380.570.120.11-0.031.0-0.24-0.16-0.56-0.18-0.110.060.471.0-0.070.07-0.47-0.370.60.741.0
0.560.820.00.650.88-0.38-0.940.030.210.38-0.370.540.70.890.730.53-0.09-0.98-0.370.350.320.84-0.37-0.58-0.83-0.37
-0.03-0.220.57-0.27-0.77-0.220.730.210.04-0.690.6-0.15-0.25-0.72-0.330.00.230.690.6-0.110.19-0.450.6-0.580.880.6
-0.29-0.520.34-0.45-0.94-0.060.930.14-0.06-0.450.74-0.35-0.46-0.93-0.52-0.260.220.90.74-0.28-0.03-0.720.74-0.830.880.74
-0.12-0.150.28-0.22-0.68-0.380.570.120.11-0.031.0-0.24-0.16-0.56-0.18-0.110.060.471.0-0.070.07-0.471.0-0.370.60.74
Click cells to compare fundamentals
Competition

CytomX Retained Earnings

Retained Earnings

(687.28 Million)

CytomX Therapeutics reported Retained Earnings of (723.45 Million) in 2023
Based on the latest financial disclosure, the price to earning indicator of CytomX Therapeutics is roughly 0.0null. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Price to Earning (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

CytomX Fundamentals

About CytomX Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CytomX Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CytomX Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CytomX Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California. Cytomx Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 174 people.

Pair Trading with CytomX Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CytomX Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with CytomX Stock

  0.67MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.61EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against CytomX Stock

  0.85KA Kineta Inc Report 29th of March 2024 PairCorr
  0.81TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.61MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.57VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.52MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to CytomX Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CytomX Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CytomX Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CytomX Therapeutics to buy it.
The correlation of CytomX Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CytomX Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CytomX Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CytomX Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CytomX Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CytomX Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytomx Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytomx Therapeutics Stock:
Check out CytomX Therapeutics Piotroski F Score and CytomX Therapeutics Altman Z Score analysis.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.
You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for CytomX Stock analysis

When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is CytomX Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CytomX Therapeutics. If investors know CytomX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CytomX Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Revenue Per Share
1.371
Quarterly Revenue Growth
0.322
Return On Assets
(0.02)
Return On Equity
(54.75)
The market value of CytomX Therapeutics is measured differently than its book value, which is the value of CytomX that is recorded on the company's balance sheet. Investors also form their own opinion of CytomX Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CytomX Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CytomX Therapeutics' market value can be influenced by many factors that don't directly affect CytomX Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CytomX Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CytomX Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CytomX Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.